Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7022993 | 0.99 | ITGB3 (0.98) | ITGB3ITGA2B | |
| SCHEMBL6156687 | 0.95 | ITGB3 (1.00) | ITGB3ITGA2B | |
| SCHEMBL6157636 | 0.91 | ITGB3 (1.00) | ITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL7293598 | 0.91 | ITGB3 (0.83) | ITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL7286913 | 0.91 | ITGB3 (0.83) | ITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL7284397 | 0.91 | ITGB3 (0.98) | ITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL7287175 | 0.91 | ITGB3 (0.98) | ITGB3ITGA2B | |
| SCHEMBL7286800 | 0.91 | ITGB3 (0.82) | ITGB3ITGA2B | |
| SCHEMBL8242148 | 0.91 | ITGB3 (0.82) | ITGB3ITGA2B | |
| SCHEMBL6156375 | 0.90 | ITGB3 (0.82) | ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0529858-B1 | 2-Piperazinone compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1997-10-15 | — | — | EP | claimed |
| US-5294713-A | Inhibiting cell adhesion | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-03-15 | — | — | US | claimed |
| EP-0529858-A1 | 2-Piperazinone compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1993-03-03 | — | — | EP | claimed |
| JP-6025285-A | — | — | None | — | — | JP | disclosed |
| US-20050187249-A1 | An aqueous solution of a physiologically active substance which may have a substituent and which has an amidino group, the solution having a pH > 2 and -/< than 4; storage stability; parental injections; 2-[4-[((3S)-1-acetoimidoyl-3-pyrrolidinyl)oxy]phenyl] -3-(7-amidino-2-naphthyl)propionic acid; kits | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-08-25 | — | — | US | disclosed |
| EP-1504755-A1 | LYOPHILIZATION PRODUCT | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-02-09 | — | — | EP | disclosed |
| US-5888531-A | ACTIVE MATERIAL STABILIZED WITH DISACCHARIDE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-03-30 | — | — | US | disclosed |
| EP-0529858-B1 | 2-Piperazinone compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1997-10-15 | — | — | EP | disclosed |
| EP-0750913-A2 | Disaccharide containing freeze-dried preparation for pharmaceutical use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-01-02 | — | — | EP | disclosed |
| US-5294713-A | Inhibiting cell adhesion | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-03-15 | — | — | US | disclosed |
| JP-H0625285-A | 2-PIPERAZINONE DERIVATIVE AND ITS USE | TAKEDA CHEM IND LTD | 1994-02-01 | — | — | JP | disclosed |
| EP-0529858-A1 | 2-Piperazinone compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1993-03-03 | — | — | EP | disclosed |
| JP-H00625285-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050187249-A1 | An aqueous solution of a physiologically active substance which may have a substituent and which has an amidino group, the solution having a pH > 2 and -/< than 4; storage stability; parental injections; 2-[4-[((3S)-1-acetoimidoyl-3-pyrrolidinyl)oxy]phenyl] -3-(7-amidino-2-naphthyl)propionic acid; kits | NGLY1, IDE, NPPA | ITGB3 3735/4885ITGA2B 3732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.